Full text is available at the source.
Abstract
Psilocybin's pharmacokinetics and pharmacodynamics involve serotonergic, neuroplastic, and anti-inflammatory mechanisms.
- Psilocybin may influence serotonin receptors, which are linked to mood and perception.
- The compound is associated with neuroplasticity, potentially supporting brain adaptability and healing.
- Anti-inflammatory properties of psilocybin could contribute to its therapeutic effects.
- The review evaluates both preclinical and clinical evidence surrounding psilocybin's safety.
- Emerging practices like microdosing are discussed regarding their potential benefits and risks.
Simplified